A novel progesterone oral formulation for the treatment of endometrial hyperplasia with reduced adverse signalling compared to synthetic progestins

A novel progesterone oral formulation for the treatment of endometrial hyperplasia with reduced adverse signalling compared to synthetic progestins

Background: Natural progesterone is currently unavailable for the treatment of endometrial hyperplasia. The first line of treatment for this condition is with the synthetic progestins Medroxyprogesterone Acetate (MPA) and Levonorgestrel (LNG). However, these hormones frequently trigger side effects...

Full description

Bibliographic Details
Main Author:	Bentham, Zoe
Published:	Swansea University 2015
Online Access:	https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.752343

Similar Items

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
by: Sahar Houshdaran, et al.
Published: (2020-04-01)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
by: Oroma Nwanodi
Published: (2017-07-01)

Contraceptive and endometrial aspects of progestins and anti-progestins
by: Hapangama, Dharani Kosala
Published: (2003)

Levonorgestrel-releasing intrauterine device versus oral progesterone for treatment of simple endometrial hyperplasia without atypia
by: Hatice Kansu-Celik, et al.
Published: (2018-03-01)

Immunohistochemical expression of estrogen and progesterone receptors in endometrial hyperplasia and endometrioid carcinoma
by: Sarmadi S, et al.
Published: (2012-06-01)

Effects of Natural Progesterone and Synthetic Progestin on Germ Layer Gene Expression in a Human Embryoid Body Model
by: Yoon Young Kim, et al.
Published: (2020-01-01)

Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
by: M. El-shamy, et al.
Published: (2012-06-01)

Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
by: Yang Hu, et al.
Published: (2021-05-01)

Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
by: Alok Pant, et al.
Published: (2012-01-01)

Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer
by: Asmerom T. Sengal, et al.
Published: (2021-04-01)

Effects of hormonal contraceptive phase and progestin generation on stress-induced cortisol and progesterone release
by: Alexandra Ycaza Herrera, et al.
Published: (2019-02-01)

Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding.
by: Ozlem Guzeloglu Kayisli, et al.
Published: (2015-01-01)

Comparative study of the molecular mechanism of action of the synthetic progestins, Medroxyprogesterone acetate and Norethisterone acetate
by: Africander, Donita Jean
Published: (2010)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
by: A.M. Newtson, et al.
Published: (2017-08-01)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
by: Yunxia Cui, et al.
Published: (2021-04-01)

Comparison the Effect of Letrozole Versus Medroxy Progesterone Acetate on Premenopausal Patients With Endometrial Hyperplasia: An Randomized clinical trial
by: Elham Rahmani, et al.
Published: (2017-07-01)

Hyperplasia and endometrial precancer
by: O. A. Gornikh, et al.
Published: (2014-08-01)

Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer
by: Yang L, et al.
Published: (2020-11-01)

Recurrent Endometrial Stromal Sarcoma: Treatment with a Progestin and Gonadotropin Releasing Hormone Agonist
by: Nefertiti Chianti duPont, et al.
Published: (2010-01-01)

Cross talk between the glucocorticoid receptor and the progesterone receptor in modulation of progestin responses and HIV-1 infection
by: Bick, Alexis J
Published: (2018)

Combined oral contraceptives in the prevention of recurrence of typical endometrial hyperplasia of endometrium
by: A L Tikhomirov
Published: (2018-08-01)

The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration
by: Ashleigh M. Byrne, et al.
Published: (2016-12-01)

Progesterone control of human endometrial cells
by: Dunn, C. L.
Published: (2003)

To the question of the pathogenesis of endometrial hyperplasia
by: A. Kh. Bishtavi, et al.
Published: (2014-07-01)

Management & prognosis of endometrial hyperplasia
by: Gallos, Ioannis D.
Published: (2014)

Progestin potency – Assessment and relevance to choice of oral contraceptives
by: Norman Goldstuck
Published: (2011-12-01)

MOLECULAR PROFILES OF ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA
by: S. A. Levakov, et al.
Published: (2018-08-01)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
by: Steven Wang, MD, et al.
Published: (2015-03-01)

Anticonceptivos orales de sólo progestina Progestin only-oral contraceptives
by: Alvaro Monterrosa
Published: (2006-03-01)

Potential alternative progestin therapy for low-grade endometrial stromal sarcoma: A case report
by: Shoji Maenohara, et al.
Published: (2020-11-01)

Modulatory Effect of Fermented Papaya Extracts on Mammary Gland Hyperplasia Induced by Estrogen and Progestin in Female Rats
by: Zhenqiang You, et al.
Published: (2017-01-01)

Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis
by: Li M, et al.
Published: (2019-05-01)

HORMONAL AND ENERGETIC CHANGES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL CANCER
by: A. L. Chernyshova, et al.
Published: (2016-02-01)

Epigenetic profile of endometrial proliferation in the different morphotypes of endometrial hyperplasia
by: O.L. Gromova, et al.
Published: (2021-03-01)

Theresults of Computer Morphometryusedin Endometrial Hyperplasia
by: Yu Yu Tabakman, et al.
Published: (2013-06-01)

Endometrial Hyperplasia; A Letter to the Editor
by: Mansour Moghimi, et al.
Published: (2012-07-01)

Endometrial Stromal Hyperplasia: An Underrecognized Condition
by: Efthimios Sivridis, et al.
Published: (2013-01-01)

An immunohistochemical study of endometrial hyperplasia and neoplasia
by: Sivridis, E.
Published: (1986)

'Endometrial Hyperplasia' Clinical and Biochemical Studies
by: Milton, P. J. D.
Published: (1978)

Progesterone's Effects on Cognitive Performance of Male Mice Are Independent of Progestin Receptors but Relate to Increases in GABAA Activity in the Hippocampus and Cortex
by: Cheryl A. Frye, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_9h9gl0bl2iprlta2004l7jg9gd